ID   ICC-X3
AC   CVCL_C8PY
DR   CCRID; 4201PAT-CCTCC02051
DR   Wikidata; Q123032654
RX   Patent=CN114717191B;
RX   PubMed=36662372;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C202260.
CC   Population: Chinese.
CC   Doubling time: ~36 hours (Patent=CN114717191B; PubMed=36662372).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Pro278Ser (c.832C>T); ClinVar=VCV000376642; Zygosity=Heterozygous (PubMed=36662372).
CC   Derived from site: In situ; Liver, intrahepatic bile duct; UBERON=UBERON_0003704.
ST   Source(s): Patent=CN114717191B; PubMed=36662372
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D12S391: 21
ST   D13S317: 8
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 11,15.2
ST   D21S11: 30,31.2
ST   D2S1338: 19,20
ST   D3S1358: 15
ST   D5S818: 11,12
ST   D6S1043: 13
ST   D7S820: 11
ST   D8S1179: 11,13
ST   FGA: 22,23
ST   Penta D: 9
ST   Penta E: 15,21
ST   TH01: 9
ST   TPOX: 9,11
ST   vWA: 14,20
DI   NCIt; C35417; Intrahepatic cholangiocarcinoma
DI   ORDO; Orphanet_70567; Cholangiocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   62Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   Patent=CN114717191B;
RA   Xu H., Zhou W.-C., Miao X., Chai C.-P., Tang H.;
RT   "Human intrahepatic bile duct cancer cell strain ICC-X3 and
RT   application thereof.";
RL   Patent number CN114717191B, 16-Jun-2023.
//
RX   PubMed=36662372; DOI=10.1007/s13577-023-00858-x;
RA   Xu H., Luo W., Zhao Z.-J., Miao X., Chai C.-P., Hu J.-J., Tang H.,
RA   Zhang H., Zhou W.-C.;
RT   "Establishment and characterization of a new intrahepatic
RT   cholangiocarcinoma cell line, ICC-X3.";
RL   Hum. Cell 36:854-865(2023).
//